E2F1-induced apoptosis: turning killers into therapeutics

Trends in Molecular Medicine
Jens Stanelle, Brigitte M Pützer

Abstract

The cellular transcription factor E2F1 is part of an anti-tumor safeguard mechanism: it engages cell-death pathways either alone or in cooperation with p53 to protect organisms from the development of tumors. E2F1 activates downstream factors, which in turn produce secondary changes in gene expression that trigger apoptosis. Although the mechanisms are incompletely understood, several studies have demonstrated that E2F1 is involved in many different aspects of programmed cell death depending on the cellular background. Here, these findings are highlighted in the context of the most recent follow-up studies that have used apoptotic E2F1 genes as new therapeutics or drug targets, thereby providing insight into the basic mechanisms of E2F1-induced apoptosis and its possible clinical implications.

References

Dec 1, 1995·Nature Medicine·M StraussJ Bartek
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·X Wu, A J Levine
Dec 1, 1995·Molecular and Cellular Biology·S W HiebertJ L Cleveland
May 17, 1996·Cell·L YamasakiN J Dyson
Aug 1, 1996·Genes & Development·K PolyakB Vogelstein
Jul 15, 1997·Genes & Development·A C PhillipsK H Vousden
Jul 23, 1998·Oncogene·C HolmbergO Karlström
Jan 5, 2000·Molecular Cell·A C PhillipsK H Vousden
Mar 25, 2000·The Journal of Investigative Dermatology·H Schlagbauer-WadlB Jansen
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·F MartelliS R Grossman
Oct 31, 2001·Molecular Cell·Y Samuels-LevX Lu
Nov 13, 2001·Oncogene·C M EischenJ L Cleveland
Feb 13, 2002·Molecular and Cellular Biology·Jamie L RussellDavid G Johnson
Feb 15, 2002·The Journal of Biological Chemistry·Thorsten StieweBrigitte M Pützer
Feb 22, 2002·Oncogene·Rhonda CroxtonW Douglas Cress
Mar 13, 2002·Archives of Biochemistry and Biophysics·Yihong MaW Douglas Cress
Apr 9, 2002·Nucleic Acids Research·Jens StanelleBrigitte M Pützer
Jun 1, 2002·Science·Guoqing Chen, David V Goeddel
Jul 9, 2002·Molecular and Cellular Biology·Harry A RogoffTimothy F Kowalik
Sep 28, 2002·Nature Immunology·Philippe Bouillet, Andreas Strasser
Apr 12, 2003·Developmental Cell·Lei Zhou, Hermann Steller
Apr 30, 2003·Nature Cell Biology·Craig StevensNicholas B La Thangue
Dec 20, 2003·The Journal of Biological Chemistry·Tzippi Hershko, Doron Ginsberg
Jan 24, 2004·Cell Cycle·Meredith S Irwin
Apr 24, 2004·The Journal of Biological Chemistry·Andre FortinRuth S Slack
May 5, 2004·The Journal of Biological Chemistry·Alessandra IanariAlberto Gulino
Nov 27, 2004·Cell Death and Differentiation·J StanelleB M Pützer
Dec 14, 2004·Cell Death and Differentiation·D ChenC D Lopez
Jan 20, 2005·Gene·Azemat Jamshidi-ParsianKelly M McMasters
Jan 29, 2005·Cancer Gene Therapy·Sanjeev DasKumaravel Somasundaram
Feb 26, 2005·Cell Death and Differentiation·V FogalX Lu
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ashraf Z BadrosRobert G Fenton
Oct 4, 2005·Developmental Cell·Nam-Sung MoonNicholas J Dyson
Feb 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·S TuveB M Pützer

❮ Previous
Next ❯

Citations

Aug 4, 2010·Breast Cancer Research and Treatment·Ensaf M Al-HujailyAbdelilah Aboussekhra
Sep 25, 2009·Nature Reviews. Cancer·Shirley Polager, Doron Ginsberg
Jul 31, 2009·Oncogene·J Yu, L Zhang
Aug 9, 2008·Journal of Biochemistry·Yuanyan WeiJianhai Jiang
Feb 22, 2011·Journal of Gastroenterology and Hepatology·Priscilla T-Y Law, Nathalie Wong
Apr 28, 2007·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jun CaoLeda Raptis
Dec 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qin Li, Guillermina Lozano
Jul 14, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lapo AlinariDavid M Lucas
Jul 18, 2012·Molecular Cancer Research : MCR·Natalia de OlanoEric W-F Lam
Dec 18, 2013·BMC Cancer·Ibtehaj Al-SharifAbdelilah Aboussekhra
Dec 17, 2009·Cellular and Molecular Life Sciences : CMLS·David EngelmannBrigitte M Pützer
Nov 18, 2010·Expert Review of Anticancer Therapy·Brigitte M PützerVijay Alla
Jul 20, 2010·Biochimica Et Biophysica Acta·Sandeep SinghSrikumar Chellappan
May 25, 2010·Trends in Molecular Medicine·Gianpiero Di Leva, Carlo M Croce
Mar 8, 2016·Cytokine & Growth Factor Reviews·Mustafa Gokhan ErtosunOzes Osman Nidai
Aug 26, 2009·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Hagit SchayekHaim Werner
Jun 23, 2009·The International Journal of Biochemistry & Cell Biology·Zhenlong WuQiang Yu
Sep 23, 2008·Trends in Cell Biology·Shirley Polager, Doron Ginsberg
Sep 5, 2008·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Carme PelegríJordi Vilaplana
May 21, 2008·Cytokine & Growth Factor Reviews·Sun-Mi Park, Marcus E Peter
Jan 16, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Dan SuHerbert Yu
Dec 21, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ester VerdaguerAntoni Camins
Jun 3, 2009·Cancer Science·Yang LiTheresa M C Tan
Oct 9, 2007·Cardiovascular Drug Reviews·Andrew W Hoel, Michael S Conte
Feb 14, 2012·The EMBO Journal·Er-Chieh ChoNicholas B La Thangue
Oct 16, 2015·The Journal of Cell Biology·Zhipeng ZouXiaochun Bai
Dec 12, 2012·Trends in Molecular Medicine·Brigitte M Pützer, David Engelmann
Sep 27, 2014·Cell Death and Differentiation·A KumariD Sakamuro
Nov 26, 2015·Analytical Cellular Pathology (Amsterdam)·Rehab M SamakaNanes S Holah
Aug 3, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David Engelmann, Brigitte M Pützer
Feb 14, 2007·Oncogene·C Berthet, P Kaldis
Mar 24, 2016·Molecular and Cellular Biology·Meenalakshmi ChinnamDavid W Goodrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis